N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide, 97%, 100mg

1-(4-Chlorophenyl)-3-phenyl-1H-pyrazol-5-ylamine, 95.0%, 100mg

1-Acetyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde, 97%, 250mg

2-bromo-4-cyano-6-methoxyphenyl acetate, 97.0%, 250mg

(2S,4R)-1-Acetyl-4-hydroxypyrrolidine-2-carboxylic acid, 95.0%, 100g

(2S)-2-[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-methylbutanamido]-5-(carbamoylamino)pentanoic acid, 98%, 10g

Viales de muestra ROTILABO® con borde rebordeado ND11, Vidrio transparente, 1,5 ml, 100 Unidad(es)

2-(4-BIPHENYLYL)-4,6-DICHLORO-1,3,5-TRIAZINE, 95.0%, 25g

Heptadec-16-enoic acid, 98%, 100mg

5-CHLORO-2-FLUORO-4-HYDROXYBENZALDEHYDE, 95.0%, 250mg

Theophylline-7-acetic acid, 98.0%, 500g

Hexacloroplatinato(IV) de potasio, mínimo 99,9 %, pa, 5 g, envase de vidrio

2-Fluoro-4,5-dimethoxyaniline, 95%, 10g